血管紧张素Ⅱ受体拮抗剂治疗充血性心力衰竭研究进展
被引量:1
摘要
血管紧张素 受体拮抗剂是治疗充血性心力衰竭的新型药物 ,由于其无血管紧张素 逃逸 ,且高效、低毒副作用 ,有望成为治疗充血性心力衰竭的重要药物之一。
出处
《心脏杂志》
CAS
2002年第2期167-169,共3页
Chinese Heart Journal
参考文献4
-
1胡厚祥,陈光辉.血管紧张素受体及其拮抗剂在心力衰竭中的作用机理[J].心功能杂志,1998,10(3):163-164. 被引量:5
-
2徐成斌.血管紧张素Ⅱ受体拮抗剂的基础特性与临床应用[J].心功能杂志,1999,11(1):36-39. 被引量:7
-
3侯应龙,臧益民.心力衰竭的分子生物学[J].心功能杂志,1998,10(2):96-97. 被引量:3
-
4杨兵生,王声愿,蒋文平.氯沙坦对充血性心衰患者血循环中肿瘤坏死因子和白介素-6的干预[J].国外医学(心血管疾病分册),2001,28(1):43-45. 被引量:5
二级参考文献6
-
1Kranzhofer R,Schmidt J,Pfeiffer CA,et al.Angiotensin induces inflammatory activation of human vascular smooth muscle cells[].Arteriosclerosis and Thrombosis.1999
-
2Hocking DC,Philips PG,Ferro TJ,et al.Mechanisms of pulmonary edema induced by tumor necrosis factor-alpha[].Circulation Research.1990
-
3Tustamoto T,Hisanaga T,Wada A,et al.Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure[].Journal of the American College of Cardiology.1998
-
4Naftilan AJ,Pratt RE,Diau VJ.Induction of platelet derived growth factor A chain and cmyc gene expressions by angiotensin Ⅱ in cultured rat vascular smooth muscle cells[].The Journal of Clinical Investigation.1989
-
5Hegewisch S,Weh HJ,Hossfeld DK.TNF-α induced cardiomyopathy[].The Lancet.1990
-
6Scheidegger KJ,Butler S,Witztum JL,et al.Angiotensin Ⅱ increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-dependent pathway[].Journal of Biological Chemistry.1997
共引文献16
-
1孙承业,曹现成.难治性心力衰竭的治疗新进展[J].工企医刊,2004,17(5):85-86.
-
2王建飞,蔡久英.心肌重构与充血性心力衰竭[J].锦州医学院学报,2004,25(4):64-67. 被引量:2
-
3黄华山.血管紧张素Ⅱ受体拮抗剂在心力衰竭中的应用及进展[J].医学文选,1999,18(4):646-648.
-
4余晨,钟良宝,梁海琴,罗长萍.科素亚与卡托普利治疗高血压的对比研究[J].海南医学院学报,2000,6(1):12-13.
-
5孙宁玲.血管紧张素转换酶及血管紧张素Ⅱ受体阻断剂的降压及器官保护的临床应用[J].河北医药,2001,23(1):7-9. 被引量:5
-
6黄林贤,余声荣,江奕文,郭兰,王坚平.洛沙坦治疗充血性心力衰竭的临床观察[J].中国综合临床,2001,17(6):423-423. 被引量:2
-
7黄林贤,郭兰,等.氯沙坦治疗充血性心力衰竭的临床观察[J].医师进修杂志,2001,24(12):28-29. 被引量:4
-
8石丹,冯治西,梁海南,姬尚义.CA125和肿瘤坏死因子α的血清浓度与慢性充血性心力衰竭相关性的临床研究[J].中华老年心脑血管病杂志,2001,3(6):379-380. 被引量:10
-
9尹瑞兴.心力衰竭的治疗进展[J].广西医学,2002,24(3):361-365. 被引量:1
-
10刘东明,张丹参.充血性心力衰竭的临床用药观察[J].张家口医学院学报,2002,19(2):54-54.
同被引文献12
-
1The Digitalis Investigation Group. The effect of digoxin on mortality And morbidity in patients with heart failure[J]. N Engl J Med, 1997,336:525--533.
-
2Moiseyev VS, Andrejevs N, Lehtonen LA, et al. The RUSSLAN Study Group. Randomized study on safety and effectiveness of levosimendan in patients with left ventricular failure after an acute myocardial hafarction[J]. J Card Fail, 1999, 5(Suppl 1) :43.
-
3Kostis JB, Rouleau JL, Pfeffer MA, et al. Beneficial effects of vasopeptidase inhibition on mortality and morbidity in heart failure: evidence from the Omapatrilat Heart Failure Pregram[J].J Am Coll Cardiol, 2000, 35 (Suppl A) : 240A.
-
4Franco-Cereceda A, McCarthy PM, Blackstone EH, et al. Partial left ventriculectomy for dilated cardiomyopathyz is this an alternative to transplantation? [J]. J Thorac Cardiovasc Surg,2001,121 (5): 879--893.
-
5Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay[J]. N Engl J Med, 2001,344(12):873--880.
-
6Packer M, Poole-Wilson P , Armstrong P,et al. Comparative effects of low and high doses of the angiotansin-converting enzyme inhibitor, lisinopril And mortality in chronic heart failure[J]. Circulation, 1999,100:1-7.
-
7Yusuf S,Sleight P,Pogue J,et al. Effects of an angiotensin-converting enzyme, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators[J]. N Engl J Med, 2000,342(3):145--153.
-
8Pott B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure[J]. N Engl J Med, 1999,341,709--717.
-
9Pitt B, Segal R, Marinez FA, et al. Effects of losartan compared with captopril in patients with symptomatic heart failure:randomized trial-the Losartan Heart Failure Survival Study ELITE Ⅱ [J]. Lancet, 2000,355:1582--1587.
-
10Cohn JN, Tognoni G. Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure[J]. N Engl J Med, 2001,345 (23):1667--1675.
-
1高洁,朱兴雷.治疗心衰的新型药物和老药新用[J].山东医药,1989,29(8):49-50.
-
2黄县立.新活素在心力衰竭中的应用效果探讨[J].中西医结合心血管病电子杂志,2015,3(29):193-194. 被引量:1
-
3虞颖茜,方居正.中医药治疗慢性心衰研究进展[J].中医临床研究,2016,8(24):88-89. 被引量:19
-
4白元鹏,薛晓文.治疗软组织肉瘤的新型药物研究进展[J].药学与临床研究,2011,19(2):142-145.
-
5严明确,白学松,任文涛.溃疡性结肠炎药物治疗的现状[J].现代医药卫生,2006,22(18):2817-2818. 被引量:5
-
6吴建亮,赵洪发,张继宝.榄香烯乳治疗恶性胸腔积液25例[J].四川肿瘤防治,2002,15(3):171-172. 被引量:1
-
7蒲健全.左氧氟沙星治疗老年社区获得性肺炎临床疗效探讨[J].医学信息(中旬刊),2010,5(8):2178-2179. 被引量:1
-
8吕静,郭丽萍.特发性肺纤维化治疗进展[J].国际呼吸杂志,2010(22):1399-1402. 被引量:2
-
9王奇,王旭燕.力克肺疾治疗肺结核的临床观察[J].山西职工医学院学报,2000,10(4).
-
10罗维俭.盐酸戊乙奎醚治疗急性有机磷农药中毒临床分析[J].国际医药卫生导报,2011,17(22):2779-2781. 被引量:3